Cowealth Medical China Co.,Ltd. (SHA:603122)

China flag China · Delayed Price · Currency is CNY
16.99
+0.21 (1.25%)
Feb 25, 2026, 4:00 PM EST
Market Cap6.76B +149.1%
Revenue (ttm)777.03M -19.9%
Net Income-11.37M
EPS-0.03
Shares Out398.05M
PE Ration/a
Forward PEn/a
Dividend0.13 (0.77%)
Ex-Dividend DateJul 14, 2025
Volume11,478,700
Average Volume26,364,138
Open16.99
Previous Close16.78
Day's Range16.70 - 17.00
52-Week Range5.56 - 31.22
Beta0.03
RSI38.52
Earnings DateMar 14, 2026

About Cowealth Medical China

Cowealth Medical China Co.,Ltd. operates as a medical company in China. It offers management services for in-vitro diagnostic reagents and consumables; platform for decision-making and analysis, commercialization of achievements in medical science and technology; a multi-channel coaxial time audio video imaging platform; and an AI-assisted system for clinical diagnosis. The company was founded in 1997 and is based in Shanghai, China. [Read more]

Sector Healthcare
Founded 1997
Employees 203
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603122
Full Company Profile

Financial Performance

In 2024, Cowealth Medical China's revenue was 939.14 million, a decrease of -14.05% compared to the previous year's 1.09 billion. Earnings were 27.57 million, a decrease of -41.58%.

Financial Statements